203 related articles for article (PubMed ID: 17852022)
1. Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.
Ajroud-Driss S; Saeed M; Khan H; Siddique N; Hung WY; Sufit R; Heller S; Armstrong J; Casey P; Siddique T; Lukas TJ
Amyotroph Lateral Scler; 2007 Oct; 8(5):305-9. PubMed ID: 17852022
[TBL] [Abstract][Full Text] [Related]
2. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
Andreadou E; Kapaki E; Kokotis P; Paraskevas GP; Katsaros N; Libitaki G; Zis V; Sfagos C; Vassilopoulos D
Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of riluzole in patients with amyotrophic lateral sclerosis.
Bruno R; Vivier N; Montay G; Le Liboux A; Powe LK; Delumeau JC; Rhodes GR
Clin Pharmacol Ther; 1997 Nov; 62(5):518-26. PubMed ID: 9390108
[TBL] [Abstract][Full Text] [Related]
4. An association study of riluzole serum concentration and survival and disease progression in patients with ALS.
Groeneveld GJ; van Kan HJ; Lie-A-Huen L; Guchelaar HJ; van den Berg LH
Clin Pharmacol Ther; 2008 May; 83(5):718-22. PubMed ID: 17898704
[TBL] [Abstract][Full Text] [Related]
5. Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.
Jiang Z; Dalton TP; Jin L; Wang B; Tsuneoka Y; Shertzer HG; Deka R; Nebert DW
Hum Mutat; 2005 Feb; 25(2):196-206. PubMed ID: 15643613
[TBL] [Abstract][Full Text] [Related]
6. [Association of cytochrome P450 genes polymorphisms (CYP1A1 and CYP1A2) with the development of chronic obstructive pulmonary disease in Bashkortostan].
Korytina GF; Akhmadishina LZ; Kochetova OV; Zagidullin ShZ; Viktorova TV
Mol Biol (Mosk); 2008; 42(1):32-41. PubMed ID: 18389617
[TBL] [Abstract][Full Text] [Related]
7. Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis.
van Kan HJ; Groeneveld GJ; Kalmijn S; Spieksma M; van den Berg LH; Guchelaar HJ
Br J Clin Pharmacol; 2005 Mar; 59(3):310-3. PubMed ID: 15752377
[TBL] [Abstract][Full Text] [Related]
8. Effect of riluzole (Rilutek) treatment on plasma amino acid percentages in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Solski J; Wawrzycki S; Szpetnar M
Neurol Sci; 2003 Nov; 24(4):290-2. PubMed ID: 14658053
[TBL] [Abstract][Full Text] [Related]
9. An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000.
Traynor BJ; Alexander M; Corr B; Frost E; Hardiman O
J Neurol; 2003 Apr; 250(4):473-9. PubMed ID: 12700914
[TBL] [Abstract][Full Text] [Related]
10. CYP1A1, CYP1A2 and CYBA gene polymorphisms associated with oxidative stress in COPD.
Vibhuti A; Arif E; Mishra A; Deepak D; Singh B; Rahman I; Mohammad G; Pasha MA
Clin Chim Acta; 2010 Apr; 411(7-8):474-80. PubMed ID: 20080081
[TBL] [Abstract][Full Text] [Related]
11. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
12. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.
Nygren I; Antonova K; Mattsson P; Askmark H
Acta Neurol Scand; 2005 Mar; 111(3):180-4. PubMed ID: 15691287
[TBL] [Abstract][Full Text] [Related]
13. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
Roch-Torreilles I; Camu W; Hillaire-Buys D
Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
[TBL] [Abstract][Full Text] [Related]
14. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
Dib M
Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
[TBL] [Abstract][Full Text] [Related]
15. What has changed with riluzole?
Meininger V; Lacomblez L; Salachas F
J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
[TBL] [Abstract][Full Text] [Related]
16. Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.
Groeneveld GJ; van Kan HJ; Toraño JS; Veldink JH; Guchelaar HJ; Wokke JH; van den Berg LH
J Neurol Sci; 2001 Oct; 191(1-2):121-5. PubMed ID: 11677002
[TBL] [Abstract][Full Text] [Related]
17. A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes.
Ueda R; Iketaki H; Nagata K; Kimura S; Gonzalez FJ; Kusano K; Yoshimura T; Yamazoe Y
Mol Pharmacol; 2006 Jun; 69(6):1924-30. PubMed ID: 16505155
[TBL] [Abstract][Full Text] [Related]
18. Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5'-flanking region.
Yoshinari K; Yoda N; Toriyabe T; Yamazoe Y
Biochem Pharmacol; 2010 Jan; 79(2):261-9. PubMed ID: 19682433
[TBL] [Abstract][Full Text] [Related]
19. A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis.
van Kan HJ; Spieksma M; Groeneveld GJ; Toraño JS; van den Berg LH; Guchelaar HJ
Biomed Chromatogr; 2004 Nov; 18(9):723-6. PubMed ID: 15386583
[TBL] [Abstract][Full Text] [Related]
20. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
